Economic evaluation of immediate administration of tranexamic acid after aneurysmal subarachnoid hemmorage
A recent randomised medical study by Hillman et al (97) has proved that an immediate administration of tranexamic acid reduced the incidence of early rebleeding after aneurismal subarachnoid haemorrhage. The cost of the tranexamic acid is negligible and has few side effects but the reduced incidence rate may have far-reaching effects on the societal and clinical treatment costs, therefore justifyi